top of page

Announcements

Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry

  • Writer: PCPC
    PCPC
  • Jul 31, 2019
  • 1 min read

The McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to  develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.


Recent Posts

See All
UVic upgrades Agilent QqQ's

In partnership with Agilent, we have upgraded 2 of our 6490 triple quadrupole mass spectrometers the the latest 6495b platforms. These...

 
 
 

Comments


Our Funding Partners

genome_canada_logo.png
CFI_WHT.png
Genome_BC_logo.png

© Pan-Canadian Proteomic Centre 2020

bottom of page